Duncan-Williams

Duncan-Williams Has Buy on Noble Corporation

Duncan Williams Downgrades Wright Medical to Hold, $18.50 PT

Duncan-Williams Reiterates Strong Buy on Ensco

Duncan Williams Downgrades Wright Medical to Hold, $18.50 PT

Duncan-Williams Reiterates Strong Buy on Ensco

Duncan-Williams Follows Up on Forest Laboratories After Icahn Crisis

UPDATE: Duncan-Williams Raises PT on Kensey Nash to $32

Duncan-Williams Follows Up on Forest Laboratories After Icahn Crisis

UPDATE: Duncan-Williams Raises PT on Kensey Nash to $32

Duncan-Williams Downgrades Endo Pharmaceuticals from Buy to Hold

Duncan Williams Raises PT On Vascular Solutions To $17

Duncan-Williams Recent News

UPDATE: Duncan-Williams Lowers PT on eResearch Technology to $8

Duncan-Williams Previews 2Q Earnings for Vascular Solutions

Duncan-Williams Reviews 2Q on Wright Medical Group

Duncan-Williams Downgrades Helmerich & Payne from Buy to Reduce

Duncan Williams Raises PT On Forest Laboratories To $48

UPDATE: Duncan-Williams Color on Salix Pharmaceuticals Upgrade

Duncan-Williams Has Buy On Endo Pharmaceuticals Holdings

Duncan-Williams Maintains Hold Rating on Cumberland Pharmaceuticals

Forest Labs and Watson Pharma to Open Near 52-Week Highs

UPDATE: Duncan-Williams Color on Forest Laboratories PT Increase

Duncan-Williams Maintains Buy on Wright Medical Group

Duncan-Williams Maintains Buy on Exactech

Duncan-Williams Reiterates Strong Buy on Atwood Oceanics

Duncan-Williams Drops Coverage of Pride International

Duncan-Williams Reiterates Strong Buy on Noble Corporation, Raises PT to $61.50

Duncan-Williams Reiterates Strong Buy and PT of $10.50 on Hercules Offshore (HERO)

Duncan-Williams Reiterates Strong Buy and PT of $68 on Ensco (ESV)

Duncan-Williams Maintains Buy Rating On Salix

Duncan-Williams Upgrades Noble Corporation to Strong Buy, PT Set to $54 (NE)

Duncan-Williams Upgrades Helmerich & Payne to Buy, PT Set to $72 (HP)

Duncan-Williams Reiterates Buy on Exactech (EXAC)

Duncan-Williams Maintains Buy on eResearch Technology (ERES)

Duncan-Williams Reiterates Reduce Rating On Helmerich & Payne (HP)